CG Oncology (CGON) Expected to Announce Quarterly Earnings on Thursday

robot
Abstract generation in progress

CG Oncology (CGON) is expected to report its Q1 2026 earnings before market open on Thursday, May 7th, with analysts forecasting ($0.58) EPS and $0.453 million in revenue. The company’s earnings call is scheduled for May 8th at 12:30 PM ET. Insider transactions show Director James Mulay sold 15,600 shares, reducing his position by 50%, while analysts presently rate the stock a “Moderate Buy” with an average price target of $79.55.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin